Delivery Order SPE2DB22D1103-SPE2DB25FTST0
- Not listed
- The Defense Logistics Agency awarded a $8,036.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a non-set-aside competitively awarded contract with performance completion scheduled for July 22, 2025, and fulfillment through AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a continuation of the company's pharmaceutical supply relationship with...
- The Defense Logistics Agency awarded a delivery order valued at $5,007.60 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used for chronic...
- The Defense Logistics Agency awarded a $40,498.66 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract, which carries no set-aside designation, was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,658.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory maintenance medication supplied in a 60-dose inhaler configuration. Awarded on July 21, 2025, with completion targeted for July 22, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $12,237.62 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used to treat chronic obstructive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,814.52 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in respiratory disease treatment. Issued on July 25, 2025, with an ultimate completion date of July 28, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,920.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price delivery order with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trelegy Ellipta (100-62.5-25) inhalation product. The order is valued at $3,922.33 and has an ultimate completion date of September 6, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $20,134.28 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract awarded on July 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $7,627.38 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed price delivery order with no set-aside designation. This contract was competitively awarded and will be performed at the vendor's corporate office...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTST0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,156.54 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The product being delivered is a combination respiratory medication used for chronic obstructive pulmonary disease management. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This master contract serves as the company's primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's consistent success in winning both set-aside and competitive federal medical supply contracts demonstrates its established capability to meet federal procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/25/25 |